Photo credit: www.sciencedaily.com

Advancements in Neural Stem Cell Transplantation for Chronic Spinal Cord Injuries

Researchers from the University of California San Diego School of Medicine have made significant strides in exploring neural stem cell transplantation as a potential treatment for chronic spinal cord injuries. A recently conducted Phase I clinical trial has shown promising long-term safety results and the feasibility of this innovative approach for a condition that often leads to debilitating paralysis. Over a period of five years, four participants with chronic spinal cord injuries were monitored, resulting in two of them demonstrating notable neurological improvements post-treatment. This was evidenced by enhanced motor and sensory scores, as well as increased electromyography (EMG) activity, with some individuals also reporting reductions in pain levels.

Neural stem cell transplantation is gaining attention as a novel intervention for a variety of neurological disorders and injuries. This technique involves the implantation of human-derived stem cells into areas of the nervous system that are damaged or diseased. The advantage of using human cells lies in their ability to potentially regenerate damaged tissues and promote integration with the patient’s existing nervous system, paving the way for recovery.

Throughout the trial, the four patients exhibited positive tolerance to the treatment, and although the primary focus was to evaluate safety and tolerability, the findings indicate that neural stem cell transplantation could hold therapeutic promise for addressing chronic spinal cord injuries. Encouraged by these outcomes, the research team is looking to move forward with a Phase II clinical trial to better assess the effectiveness of the treatment.

The research, which has been documented in the December 17 issue of Cell Reports Medicine, was spearheaded by Dr. Joseph Ciacci, a prominent figure in the Department of Neurological Surgery at UC San Diego School of Medicine, alongside Dr. Joel Martin, who was a neurological surgery resident at the time and has since become a neurosurgeon at Orlando Health. Their work received backing from the California Institute of Regenerative Medicine (CIRM) in partnership with the UC San Diego Alpha Stem Cell Clinic and the Sanford Stem Cell Clinical Center, underlining collaborative efforts to advance regenerative medicine.

Source
www.sciencedaily.com